Status:
COMPLETED
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
US Endoscopy
Conditions:
Neoplasms
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon. The investigators also will compare two solutions used during the procedure to determine if either so...
Detailed Description
The primary aim of the study is to compare the efficacy, efficiency and safety of two types of snares used in Endoscopic Mucosal Resection (EMR), a combined needle and snare unit (ISnare, US Endoscopy...
Eligibility Criteria
Inclusion
- Sessile colorectal polyp
- laterally spreading lesions as defined by Paris Classification type II and \> 1 cm or greater
Exclusion
- Those with ulcerated depressed lesions (Paris type III) or biopsy proven invasive carcinoma
- Inflammatory bowel disease patients
- Coagulopathy ( INR\> 1.5) that cannot be corrected
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01471756
Start Date
October 1 2011
End Date
May 1 2014
Last Update
September 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224